financetom
BSBR
financetom
/
Financials
/
BSBR
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Banco Santander (Brasil) S.A.BSBR
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Banco Santander (Brasil) S.A., together with its subsidiaries, provides various banking products and services to individuals, small and medium enterprises, and corporate customers in Brazil and internationally.

The company operates through, Commercial Banking and Global Wholesale Banking segments. It offers deposits and other bank funding instruments; debit and credit cards; digital prepaid solutions; payment platform; loyalty programs; employee benefit vouchers; payroll loans; digital lending and online debt renegotiation platform; mortgages; home equity financing products; consumer credit; and local loans, commercial and trade finance, guarantees, structured loans, and cash management and funding solutions, as well as on-lending transfer services.

It also provides financing and financial advisory services related to projects, origination and distribution of fixed income securities in the debt capital markets, financing of acquisitions and syndicated loans, other structured financing arrangements, and subordinated debts; and advisory services for mergers and acquisitions, and equity capital markets transactions.

In addition, the company structures and offers foreign exchange, derivative, and investment products for institutional investors, and corporate and retail customers; and provides market making services.

Further, it offers instant payment services; range of products and services focused on the agribusiness sector; and microfinance services, as well as digital trading platform.

Additionally, it provides its financial services and products to its customers through multichannel distribution network comprising branches, mini-branches, ATMs, call centers, Internet banking, and mobile banking.

Banco Santander (Brasil) S.A. was incorporated in 1985 and is headquartered in São Paulo, Brazil.

Latest News >
GM, LG to make new, lower-cost cells for future EVs
GM, LG to make new, lower-cost cells for future EVs
May 26, 2025
DETROIT (Reuters) -General Motors ( GM ) and battery partner LG Energy Solution are planning to start commercial production of lower-cost cells for future electric vehicles at a U.S. facility starting in 2028, the companies said on Tuesday.  The cells will have a lithium manganese-rich (LMR) chemistry, which GM says is lower cost than the nickel-rich cells used today, but...
OMS Energy Technologies Prices 3.7 Million Share IPO at $9 per Share
OMS Energy Technologies Prices 3.7 Million Share IPO at $9 per Share
May 26, 2025
10:05 AM EDT, 05/13/2025 (MT Newswires) -- OMS Energy Technologies ( OMSE ) said Tuesday it priced its initial public offering of about 3.7 million ordinary shares at $9 per share. The total base offering size is $33.3 million, assuming the underwriters don't exercise their 45-day option to buy up to 555,555 additional ordinary shares at the IPO price, the...
Bank of America to open more than 150 new branches by 2027
Bank of America to open more than 150 new branches by 2027
May 26, 2025
May 13 (Reuters) - Bank of America ( BAC ) plans to open more than 150 new branches by the end of 2027, it said on Tuesday, as part of the lender's efforts to expand its physical presence across the United States. The bank will open 40 new branches this year, with an additional 70 sites planned for 2026, it...
Bright Minds Biosciences Says BMB-101 Eliminated Drop Attacks in Mouse Model of Epilepsy
Bright Minds Biosciences Says BMB-101 Eliminated Drop Attacks in Mouse Model of Epilepsy
May 26, 2025
10:03 AM EDT, 05/13/2025 (MT Newswires) -- Bright Minds Biosciences ( DRUG ) said Tuesday that its BMB-101 showed a complete elimination of drop attacks in the DBA/2 mouse model of epilepsy. Notably, BMB-101 achieved 100% survival in the DBA/2 model, reversing brainstem serotonin deficits and preventing seizure-induced respiratory arrest, Jan Torleif Pedersen, the company's chief science officer, said. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved